Cost-Effectiveness of Quantiferon®-TB Gold-In-Tube Versus Tuberculin Skin Testing for Contact Screening and Treatment of Latent Tuberculosis Infection in Brazil

BACKGROUND: Latent tuberculosis infection (LTBI) is a reservoir for new TB cases. Isoniazid preventive therapy (IPT) reduces the risk of active TB by as much as 90%, but LTBI screening has limitations. Unlike tuberculin skin testing (TST), interferon-gamma release assays are not affected by BCG vacc...

Descripción completa

Detalles Bibliográficos
Autores principales: Steffen, Ricardo Ewbank, Caetano, Rosângela, Pinto, Márcia, Chaves, Diogo, Ferrari, Rossini, Bastos, Mayara, de Abreu, Sandra Teixeira, Menzies, Dick, Trajman, Anete
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3617186/
https://www.ncbi.nlm.nih.gov/pubmed/23593145
http://dx.doi.org/10.1371/journal.pone.0059546

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3617186/
https://www.ncbi.nlm.nih.gov/pubmed/23593145
http://dx.doi.org/10.1371/journal.pone.0059546

Ejemplares similares